Literature DB >> 16452532

Vascular and renal function in experimental thyroid disorders.

Félix Vargas1, Juan Manuel Moreno, Isabel Rodríguez-Gómez, Rosemary Wangensteen, Antonio Osuna, Miriam Alvarez-Guerra, Joaquín García-Estañ.   

Abstract

This review focuses on the effects of thyroid hormones in vascular and renal systems. Special emphasis is given to the mechanisms by which thyroid hormones affect the regulation of body fluids, vascular resistance and, ultimately, blood pressure. Vascular function is markedly affected by thyroid hormones that produce changes in vascular reactivity and endothelial function in hyper- and hypothyroidism. The hypothyroid state is accompanied by a marked decrease in sensitivity to vasoconstrictors, especially to sympathetic agonists, alteration that may play a role in the reduced blood pressure of hypothyroid rats, as well as in the preventive effects of hypothyroidism on experimental hypertension. Moreover, in hypothyroid rats, the endothelium-dependent and nitric oxide donors vasodilation is reduced. Conversely, the vessels from hyperthyroid rats showed an increased endothelium-dependent responsiveness that may be secondary to the shear-stress induced by the hyperdynamic circulation, and that may contribute to the reduced vascular resistance characteristic of this disease. Thyroid hormones also have important effects in the kidney, affecting renal growth, renal haemodynamics, and salt and water metabolism. In hyperthyroidism, there is a resetting of the pressure-natriuresis relationship related to hyperactivity of the renin-angiotensin system, which contributes to the arterial hypertension associated with this endocrine disease. Moreover, thyroid hormones affect the development and/or maintenance of various forms of arterial hypertension. This review also describes recent advances in our understanding of thyroid hormone action on nitric oxide and oxidative stress in the regulation of cardiovascular and renal function and in the long-term control of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452532     DOI: 10.1530/eje.1.02093

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  64 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  An easily overlooked cause of acute kidney injury: Answers.

Authors:  Sare Gülfem Özlü; Zehra Aydin; Aylin Kilinç Uğurlu; Mehmet Boyraz; Umut Selda Bayrakçı
Journal:  Pediatr Nephrol       Date:  2021-01-07       Impact factor: 3.714

3.  Evaluation and comparison of Abbott Jaffe and enzymatic creatinine methods: Could the old method meet the new requirements?

Authors:  Tuncay Küme; Barıs Sağlam; Cem Ergon; Ali Rıza Sisman
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

4.  Regulation of expression of antioxidant enzymes by vitamin E and curcumin in L-thyroxine-induced oxidative stress in rat renal cortex.

Authors:  Srikanta Jena; Gagan Bihari Nityananda Chainy
Journal:  Mol Biol Rep       Date:  2010-06-24       Impact factor: 2.316

Review 5.  Pulmonary hypertension in thyroid diseases.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Francesco Tunzi; Gabriella Ricci; Santa Carbonara; Fiorella Devito; Annapaola Zito; Anna Ciampolillo; Marco Matteo Ciccone
Journal:  Endocrine       Date:  2016-03-19       Impact factor: 3.633

Review 6.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

7.  Novel cell-based assay for detection of thyroid receptor beta-interacting environmental contaminants.

Authors:  Diana A Stavreva; Lyuba Varticovski; Ludmila Levkova; Anuja A George; Luke Davis; Gianluca Pegoraro; Vicki Blazer; Luke Iwanowicz; Gordon L Hager
Journal:  Toxicology       Date:  2016-08-12       Impact factor: 4.221

8.  Effects of clofibrate on salt loading-induced hypertension in rats.

Authors:  Antonio Cruz; Isabel Rodríguez-Gómez; Rocío Pérez-Abud; Miguel Ángel Vargas; Rosemary Wangensteen; Andrés Quesada; Antonio Osuna; Juan Manuel Moreno
Journal:  J Biomed Biotechnol       Date:  2010-10-14

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

10.  Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.

Authors:  Javier Carmona-Cortés; Isabel Rodríguez-Gómez; Rosemary Wangensteen; Inmaculada Banegas; Ángel M García-Lora; Andrés Quesada; Antonio Osuna; Félix Vargas
Journal:  Tumour Biol       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.